Head-to-Head

Abbott Laboratories vs. Janux Therapeutics, Inc. Common Stock

ABT

Abbott Laboratories

$110.51 +0.53%

VS JANX

Janux Therapeutics, Inc. Common Stock

$12.76 -27.62%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTJANX
Market Cap $190.39 billion $1.08 billion

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTJANX
Dividend Yield 2.28% —

ABT and JANX split the dividend factors evenly.

Risk & Sentiment

ABTJANX
Short Interest 0.57% 0.65%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, JANX overview, JANX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.